Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report

Sorafenib is a tyrosine kinase inhibitor that has been demonstrated to improve the overall survival time of patients with advanced hepatocellular carcinoma (HCC). Although there have been a number of reports of patients achieving complete remission (CR) following sorafenib therapy, the long-term cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Park, Jung Gil, Tak, Won Young, Park, Soo Young, Kweon, Young Oh, Jang, Se Young, Lee, Soo Hyun, Lee, Yu Rim, Jang, Sun Kyung, Hur, Keun, Lee, Heon Ju
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5649582/
https://ncbi.nlm.nih.gov/pubmed/29085491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados